206 related articles for article (PubMed ID: 18803071)
1. A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP).
Barna BP; Malur A; Dalrymple H; Karnekar R; Culver DA; Abraham S; Singh RJ; Brescia D; Kavuru MS; Thomassen MJ
Autoimmunity; 2009 Jan; 42(1):56-62. PubMed ID: 18803071
[TBL] [Abstract][Full Text] [Related]
2. Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF.
Bonfield TL; Barna BP; John N; Malur A; Culver DA; Kavuru MS; Thomassen MJ
J Autoimmun; 2006 Feb; 26(1):37-41. PubMed ID: 16337108
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect.
Thomassen MJ; Yi T; Raychaudhuri B; Malur A; Kavuru MS
Clin Immunol; 2000 May; 95(2):85-92. PubMed ID: 10779401
[TBL] [Abstract][Full Text] [Related]
4. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ
J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
[TBL] [Abstract][Full Text] [Related]
5. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression.
Bonfield TL; John N; Malur A; Barna BP; Culver DA; Kavuru MS; Thomassen MJ
Clin Immunol; 2005 Jan; 114(1):79-85. PubMed ID: 15596412
[TBL] [Abstract][Full Text] [Related]
6. Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes.
Dalrymple H; Barna BP; Malur A; Malur AG; Kavuru MS; Thomassen MJ
BMC Immunol; 2013 Sep; 14():41. PubMed ID: 24044676
[TBL] [Abstract][Full Text] [Related]
7. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
Huizar I; Kavuru MS
Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
[TBL] [Abstract][Full Text] [Related]
8. [The pulmonary expression of granulocyte-macrophage colony-stimulating factor and surfactant protein in adult idiopathic pulmonary alveolar proteinosis].
Zhou XM; Bai JW; Cai HR; Wu HY; Chen J
Zhonghua Nei Ke Za Zhi; 2005 Nov; 44(11):832-5. PubMed ID: 16316563
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary alveolar proteinosis.
Presneill JJ; Nakata K; Inoue Y; Seymour JF
Clin Chest Med; 2004 Sep; 25(3):593-613, viii. PubMed ID: 15331195
[TBL] [Abstract][Full Text] [Related]
10. Extra-pulmonary aspects of acquired pulmonary alveolar proteinosis as predicted by granulocyte-macrophage colony-stimulating factor-deficient mice.
Seymour JF
Respirology; 2006 Jan; 11 Suppl():S16-22. PubMed ID: 16423263
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary alveolar proteinosis.
Wang T; Lazar CA; Fishbein MC; Lynch JP
Semin Respir Crit Care Med; 2012 Oct; 33(5):498-508. PubMed ID: 23001804
[TBL] [Abstract][Full Text] [Related]
12. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
Xu KF; Chen Y; Guo ZJ; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma is deficient in alveolar macrophages from patients with alveolar proteinosis.
Bonfield TL; Farver CF; Barna BP; Malur A; Abraham S; Raychaudhuri B; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2003 Dec; 29(6):677-82. PubMed ID: 12805087
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Alveolar Proteinosis: recent advances.
Mazzone PJ; Jane Thomassen M; Kavuru MS
Semin Respir Crit Care Med; 2002 Apr; 23(2):115-26. PubMed ID: 16088604
[TBL] [Abstract][Full Text] [Related]
15. Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung?
Nakata K; Kanazawa H; Watanabe M
Respirology; 2006 Jan; 11 Suppl():S65-9. PubMed ID: 16423275
[TBL] [Abstract][Full Text] [Related]
16. Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.
Malur A; Kavuru MS; Marshall I; Barna BP; Huizar I; Karnekar R; Thomassen MJ
Respir Res; 2012 Jun; 13(1):46. PubMed ID: 22697800
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of surfactant protein production in a mouse model of secondary pulmonary alveolar proteinosis.
Shibasaki M; Hashimoto K; Okamoto M; Hayashi Y; Imaizumi K; Hashimoto N; Ozaki N; Yokoi T; Takagi K; Hasegawa Y; Shimokata K; Kawabe T
Am J Respir Cell Mol Biol; 2009 May; 40(5):536-42. PubMed ID: 18931325
[TBL] [Abstract][Full Text] [Related]
18. Immune dysregulation in the pathogenesis of pulmonary alveolar proteinosis.
Martinez-Moczygemba M; Huston DP
Curr Allergy Asthma Rep; 2010 Sep; 10(5):320-5. PubMed ID: 20623372
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Alveolar Proteinosis Syndrome.
Suzuki T; Trapnell BC
Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
[TBL] [Abstract][Full Text] [Related]
20. Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response.
Malur A; Mccoy AJ; Arce S; Barna BP; Kavuru MS; Malur AG; Thomassen MJ
J Immunol; 2009 May; 182(9):5816-22. PubMed ID: 19380830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
